Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilo Jimenez

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
Cancers|July 24, 2019
Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 MetaiodobenzylguanidineCamilo Jimenez, William Erwin, Beth Chasen
The New England Journal of Medicine|February 11, 2026
Belzutifan for Advanced Pheochromocytoma or Paraganglioma. ReplyCamilo Jimenez, Mikkel Andreassen, Alfredo Berruti
Clinical Nuclear Medicine|February 9, 2023
Proposed MIBG Scan-Based Tumor Response Criteria of High-Specific-Activity 131 I-MIBG Therapy in Metastatic Pheochromocytoma/ParagangliomaYang Lu, Guofan Xu, Camilo Jimenez
Endocrine-Related Cancer|May 6, 2020
Antiangiogenic therapies for pheochromocytoma and paragangliomaCamilo Jimenez, Sasan Fazeli, Alejandro Román-Gonzalez
Molecular and Cellular Endocrinology|August 25, 2024
Metastatic pheochromocytoma and paraganglioma: Integrating tumor biology in clinical practiceJeena Varghese, Catherine M Skefos, Camilo Jimenez
Endocrine Reviews|July 20, 2019
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and BeyondMaria E Cabanillas, Mabel Ryder, Camilo Jimenez
The Journal of Clinical Endocrinology and Metabolism|September 20, 2014
Medullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat--and with which drug--those are the questionsMaria E Cabanillas, Mimi I Hu, Camilo Jimenez
The American Journal of Surgical Pathology|July 19, 2021
Pheochromocytoma: A Clinicopathologic and Molecular Study of 390 Cases From a Single CenterZhonghua Liu, Junsheng Ma, Camilo Jimenez, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|June 15, 2026
Multiple endocrine neoplasia type 2: From molecular genetics to precision therapyDaniel Bulzico, Elisa Lamback, Catherine Skefos, et al.
Endocrinology and Metabolism Clinics of North America|June 4, 2014
Update on medullary thyroid cancerMimi I Hu, Anita K Ying, Camilo Jimenez
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
Cancers|July 24, 2019
Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 MetaiodobenzylguanidineCamilo Jimenez, William Erwin, Beth Chasen
The New England Journal of Medicine|February 11, 2026
Belzutifan for Advanced Pheochromocytoma or Paraganglioma. ReplyCamilo Jimenez, Mikkel Andreassen, Alfredo Berruti
Clinical Nuclear Medicine|February 9, 2023
Proposed MIBG Scan-Based Tumor Response Criteria of High-Specific-Activity 131 I-MIBG Therapy in Metastatic Pheochromocytoma/ParagangliomaYang Lu, Guofan Xu, Camilo Jimenez
Endocrine-Related Cancer|May 6, 2020
Antiangiogenic therapies for pheochromocytoma and paragangliomaCamilo Jimenez, Sasan Fazeli, Alejandro Román-Gonzalez
Molecular and Cellular Endocrinology|August 25, 2024
Metastatic pheochromocytoma and paraganglioma: Integrating tumor biology in clinical practiceJeena Varghese, Catherine M Skefos, Camilo Jimenez
Endocrine Reviews|July 20, 2019
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and BeyondMaria E Cabanillas, Mabel Ryder, Camilo Jimenez
The Journal of Clinical Endocrinology and Metabolism|September 20, 2014
Medullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat--and with which drug--those are the questionsMaria E Cabanillas, Mimi I Hu, Camilo Jimenez
The American Journal of Surgical Pathology|July 19, 2021
Pheochromocytoma: A Clinicopathologic and Molecular Study of 390 Cases From a Single CenterZhonghua Liu, Junsheng Ma, Camilo Jimenez, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|June 15, 2026
Multiple endocrine neoplasia type 2: From molecular genetics to precision therapyDaniel Bulzico, Elisa Lamback, Catherine Skefos, et al.
Endocrinology and Metabolism Clinics of North America|June 4, 2014
Update on medullary thyroid cancerMimi I Hu, Anita K Ying, Camilo Jimenez
Pageof 15